Direkt zum Inhalt

MIEHLKE, S. ; HANSKY, K. ; SCHNEIDER‐BRACHERT, W. ; KIRSCH, C. ; MORGNER, A. ; MADISCH, A. ; KUHLISCH, E. ; BÄSTLEIN, E. ; JACOBS, E. ; BAYERDÖRFFER, E. ; LEHN, N. ; STOLTE, M.

Randomized trial of rifabutin‐based triple therapy and high‐dose dual therapy for rescue treatment of Helicobacter pylori resistant to both metronidazole and clarithromycin

MIEHLKE, S., HANSKY, K., SCHNEIDER‐BRACHERT, W., KIRSCH, C., MORGNER, A., MADISCH, A., KUHLISCH, E., BÄSTLEIN, E., JACOBS, E., BAYERDÖRFFER, E., LEHN, N. and STOLTE, M. (2006) Randomized trial of rifabutin‐based triple therapy and high‐dose dual therapy for rescue treatment of Helicobacter pylori resistant to both metronidazole and clarithromycin. Alimentary Pharmacology & Therapeutics 24 (2), pp. 395-403.

Date of publication of this fulltext: 19 Dec 2024 14:35
Article



Involved Institutions


Details

Item typeArticle
Journal or Publication TitleAlimentary Pharmacology & Therapeutics
Publisher:BLACKWELL PUBLISHING
Place of Publication:OXFORD
Volume:24
Number of Issue or Book Chapter:2
Page Range:pp. 395-403
Date2006
InstitutionsMedicine > Lehrstuhl für Medizinische Mikrobiologie und Hygiene
Identification Number
ValueType
10.1111/j.1365-2036.2006.02993.xDOI
KeywordsPROTON PUMP INHIBITOR; 2 ERADICATION TREATMENTS; ANTIMICROBIAL RESISTANCE; 2ND-LINE TREATMENT; QUADRUPLE THERAPY; GENOTYPIC DIFFERENCES; CONSENSUS CONFERENCE; TREATMENT FAILURES; INFECTED PATIENTS; PLUS AMOXICILLIN;
Dewey Decimal Classification600 Technology > 610 Medical sciences Medicine
StatusPublished
RefereedYes, this version has been refereed
Created at the University of RegensburgYes
Item ID69918

Export bibliographical data

Owner only: item control page

nach oben